AstraZeneca · 14 hours ago
Associate Principal Scientist, Vector Engineering and Cell Line Development
AstraZeneca is a leading pharmaceutical company focused on innovation and delivering life-changing medicines. They are seeking an Associate Principal Scientist to drive vector engineering and cell line development for lentiviral vector manufacturing, playing a critical role in building a high-performing function that accelerates their Cell Therapy modalities portfolio.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Design, build, and optimize plasmids and expression cassettes (promoters, enhancers, codon usage, ITR/LTR elements, insulators, ORF engineering) to increase vector productivity and quality while reducing recombination risks and plasmid burden
Engineer vectors with built-in safety controls (split genomes, self-inactivating elements), reduce RCL risk, and minimize integration-competent vector species; align designs with global regulatory expectations and internal quality standards
Evaluate and implement cell substrates for viral vector production, including transient transfection systems, stable packaging lines, and producer cell lines; compare productivity, product quality, cost, and scalability
Generate and characterize stable clones (vector integration, copy number, expression stability, growth/production kinetics); implement selection strategies and gene/vector architectures to enhance stability and yield
Collaborate with internal and external partners, contribute to the development of inducible/regulated producer cell lines; assess leakiness, cytotoxicity, and long-term stability; design induction strategies compatible with GMP manufacturing
Define and execute characterization plans linking design choices to critical quality attributes (genome integrity, potency, residuals, empty/full ratios); collaborate with Analytical Development on assays (qPCR/ddPCR, NGS, ELISA, infectivity/potency)
Prepare technical reports, clone/construct histories, sequence maps, and development summaries; author transfer packages and support implementation at pilot and GMP sites in alignment with cGMP and data integrity expectations
Working with upstream (bioreactor), downstream (purification), and analytical teams to translate designs into scalable, phase-appropriate processes
Evaluate next-generation vector backbones, promoters, regulatory elements, and cell engineering tools; assess new cell hosts and media/feed platforms for improved manufacturability
Qualification
Required
PhD in Molecular Biology, Cell Biology, Bioengineering, Virology, or related field with 5–8 years of industry experience or MS with 10+ years
Hands-on experience in plasmid/vector engineering and mammalian cell line development for viral vectors in development or manufacturing contexts
Plasmid construct design, cloning, sequence verification, and optimization for expression and manufacturability
Mammalian cell culture in adherent and suspension; development of stable packaging and/or producer lines, including vector integration strategies and clone screening
Transient transfection optimization at bench and pilot scales; familiarity with single-use bioreactors and scalable transfection workflows
Understanding of vector biology and biosafety (e.g., RCL/RCA risk, helper functions, split genomes, SIN LTRs)
Proficiency with qPCR/ddPCR, sequencing, and relevant product analytics; working knowledge of DOE and statistical analysis
Familiarity with cGMP expectations for starting materials (plasmids, cell banks) and phase-appropriate documentation; experience contributing to CMC sections is a plus
Strong written and verbal communication; ability to work cross-functionally and translate designs into process requirements
Preferred
Experience creating inducible producer cell lines and assessing stability across passages and induction cycles
Background in genome engineering (CRISPR/Cas, recombinase-mediated cassette exchange, safe-harbor integration, landing pad strategies)
Experience with high-throughput clone screening, automation, and electronic lab systems (ELN/LIMS)
Demonstrated linkage of vector/cell design changes to manufacturing KPIs (titer, potency, impurity profile, empty/full, RCL/RCA)
Benefits
Short-term incentive bonus opportunity
Equity-based long-term incentive program
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
H1B Sponsorship
AstraZeneca has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2021 (2)
2020 (11)
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Leadership Team
Recent News
2026-01-09
2026-01-09
News Powered by Cision
2026-01-08
Company data provided by crunchbase